What terminal half-life was measured for Elocta (efmoroctocog alfa) using the one-stage clotting assay in previously treated patients aged 15 years or older with severe haemophilia A?

Elocta (efmoroctocog alfa) had a geometric mean terminal half-life of 19.0 hours (95% CI 17.0–21.1) using the one-stage clotting assay after a single 50 IU/kg dose in 28 previously treated patients aged ≥15 years with severe haemophilia A.